![Jean-Gabriel Judde](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jean-Gabriel Judde
Fundador en XenTech SAS .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Pascal Leuraud | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | 18 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Arnaud Beurdeley | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | - |
Marie-Emmanuelle Legrier | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | - |
Bertrand Coulomb | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | - |
Jean-Marc Husson | M | - |
Université Paris Diderot-Paris 7
| 3 años |
Delphine Nicolle | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | - |
Ludovic Bourre | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | - |
Sabrina Serpillon | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | - |
Paola Bazzacco | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | - |
Jerome Cheng | M | 70 |
Université Paris Diderot-Paris 7
| 4 años |
Antoine Petit | M | 64 |
Université Paris Diderot-Paris 7
| 3 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Francia | 11 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Jean-Gabriel Judde
- Red Personal